Phase 2b Study of an Ad26.RSV.preF Vaccine for Prevention of RSV-mediated Respiratory Tract Disease in Older Adults

Respiratory syncytial virus (RSV) may cause serious lower respiratory tract disease (LRTD) in older adults, and there is currently no licensed vaccine. CYPRESS (NCT03982199) is a randomized, double-blind, placebo-controlled Phase 2b proof-of-concept trial of an Ad26.RSV.preF-based vaccine for the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Falsey, Ann, Williams, Kristi, Gymnopoulou, Efi, Bart, Stephan, Ervin, John, De Paepe, Els, Comeaux, Christy, Heijnen, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682535/
http://dx.doi.org/10.1093/geroni/igab046.3723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682535/
http://dx.doi.org/10.1093/geroni/igab046.3723

Ejemplares similares